The U.S. Food and Drug Administration (FDA) this week announced an extension to a May 16th Federal Register notice requesting industry comments and records on substances used in animal feed. FDA had originally published a 60-day notice requesting public comment on the proposed collection of information, and no comments were received.
According to the Federal Register notice, this regulation requires renderers, feed manufacturers, and others involved in feed and feed ingredient manufacturing and distribution to maintain written procedures specifying the cleanout procedures or other means, and specifying the procedures for separating products that contain or may contain protein derived from mammalian tissue from all other protein products from the time of receipt until the time of shipment. These written procedures are intended to help the firm formalize their processes, and then to help inspection personnel confirm that the firm is operating in compliance with the regulation.
According to FDA, these written procedures must be maintained as long as the facility is operating in a manner that necessitates the record, and if the facility makes changes to an applicable procedure or process the record must be updated. Written procedures required by this section shall be made available for inspection and copying by FDA.
The extended deadline for public comment is September 26, 2013. Detailed submission information is available here.
FDA Announces Extension to Comment Period for Substances Prohibited from Use in Animal Feed
The U.S. Food and Drug Administration (FDA) this week announced an extension to a May 16th Federal Register notice requesting industry comments and records on substances used in animal feed. FDA had originally published a 60-day notice requesting public comment on the proposed collection of information, and no comments were received.
According to the Federal Register notice, this regulation requires renderers, feed manufacturers, and others involved in feed and feed ingredient manufacturing and distribution to maintain written procedures specifying the cleanout procedures or other means, and specifying the procedures for separating products that contain or may contain protein derived from mammalian tissue from all other protein products from the time of receipt until the time of shipment. These written procedures are intended to help the firm formalize their processes, and then to help inspection personnel confirm that the firm is operating in compliance with the regulation.
According to FDA, these written procedures must be maintained as long as the facility is operating in a manner that necessitates the record, and if the facility makes changes to an applicable procedure or process the record must be updated. Written procedures required by this section shall be made available for inspection and copying by FDA.
The extended deadline for public comment is September 26, 2013. Detailed submission information is available here.